NOVTNovanta Inc.
Price
+23%1YEnd-of-day closes, not the intraday tick.
A mixed picture: the questions disagree
Quality mixed, nothing alarming, demanding price, growth fading, the market undecided.
Novanta Inc. and its subsidiaries (collectively referred to as the “Company”, “Novanta”, “we”, “us”, “our”) is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial original equipment manufacturers (“OEMs”) a competitive advantage. We combine deep proprietary technology expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and advanced surgery with a proven ability to solve complex technical challenges.
In the company’s own words · 10-K filed Feb 23, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Novanta Inc. (NOVT) reported revenue of $266M in Q2 2026 (quarter ended Jul 3, 2026), up 10% from the same quarter a year earlier. That came with a gross margin of 45% and net income of $13M (4.7% of revenue). For the full year FY2025, revenue was $981M (+3.3% year on year) and net income $54M. Its largest segment in Q2 2026 was Robotics And Automation at $88M, 33% of the disclosed total, ahead of Advanced Surgery at 25%. The next results filing is expected around Nov 2, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Oct 2, 2026Consolidated Financial Statements and Report of Independent Certified Public Accountants.Material event (exhibits only) · press release
- Aug 5, 2026Novanta Announces Financial Results.Earnings release · press release
- Jul 27, 2026As previously disclosed in the Current Report on Form 8-K filed on June 8, 2026 (the “Previous Form 8-K”), by Novanta Inc., a Canadian corporation (the “Company”) with the Securities and Exchange Commission, on June 8, 2026, the Company, Novanta Medical Technologies Corp., a Delaware corporation and an indirect …Acquisition or disposition completed · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Jun 2026 · $265.8MThe company’s own SEC segment disclosure.
- Robotics And Automation$88.4M33%
- Advanced Surgery$67.5M25%
- Precision Medicine$62.1M23%
- Precision Manufacturing$47.8M18%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Scientific & Technical Instruments
Ranks #6 of 12 by RyuScore